Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Report

Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component (Oxygenator, Pumps), By Modality, By Patient Type, By Application, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Dec, 2020
  • Base Year for Estimate: 2020
  • Report ID: GVR-1-68038-001-9
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 110

Report Overview

The global extracorporeal membrane oxygenation machine market size was valued at USD 202.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.1% from 2021 to 2028. The rising incidence of cardiopulmonary disease and respiratory failure is one of the key drivers of extracorporeal membrane oxygenation (ECMO) machine market. According to the Centers for Disease Control and Prevention (CDC), an individual dies every 37 seconds from cardiovascular disease in the U.S. Furthermore, chronic obstructive pulmonary disease (COPD) was among the leading causes of death in the U.S. in 2018. The increasing number of hospitals offering ECMO services and the rising number of awareness programs are some of the factors boosting the market growth. According to the Federal Agency of Health Research and Quality, there were 6890 ECMO procedures performed in the U.S. in 2014. Thereafter, the adoption of ECMO machines in hospitals has been increased significantly.

U.S. ECMO machine market size, by modality, 2016 - 2028 (USD Million)

According to the Extracorporeal Life Support Organization (ELSO), the number of hospitals offering ECMO services reached 264 in 2019 up from 108 in 2008. ECMO devices are being used in the treatment of serious COVID-19 patients. However, other applications of these devices, including heart procedures, showed a sharp decline in 2020. Increasing awareness about ECMO procedures and technological advancement is further propelling the market growth. Many government organizations are aimed to create awareness about ECMO Procedures. Initiatives such as the Global Initiative for Chronic Obstructive Lung Disease (GOLD) aim at creating awareness about COPD along with its treatment, which includes the usage of ECMO devices.

Furthermore, the increasing adoption rate of ECMO machines is catalyzing technological advancement in these systems. The latest advancements include oxygenators, hollow pumps, and heparin-coated cannula used for various applications in surgeries. In addition, recently developed ECMO machines are smaller in size, thus increasing their portability and applications. Portable adaptors and compact ECMO machine circuits have also been developed, which help in the transportation of critically ill patients.

COVID19 impact: Market declined by around 25% from 2019

Pandemic Impact

Post COVID Outlook

ECMO machines have been a lifesaver for severe COVID-19 patients; however, their use is limited due to strict regulations.

The demand for ECMO systems is expected to grow at more than a CAGR of 5% from 2021 to 2028. The growth surge is expected to reflect the stocking up of ECMO devices by major hospitals for pandemic-like situations.

Overall market saw around 70% decline during the first wave of pandemic

According to various studies, weakened immunity of COVID-19 patients and long-term symptoms are expected to increase the cases of organ failure and demand for ECMO devices in upcoming years

 

The growing geriatric population, coupled with the increasing incidence of coronary heart disease, is boosting the adoption of ECMO machines. Coronary heart disease is strongly associated with age and is one of the leading causes of death worldwide. According to the United Nations, the number of people aged 80 years or more is projected to reach 426 million by 2050 from 143 million in 2019 globally. However, complications associated with ECMO machines, such as infections, technical failure, bleeding, and high cost of treatment, may hinder the growth of the market.

Component Insights

The oxygenator segment accounted for the largest share of 34.1% in 2020 and is expected to grow at a lucrative rate during the forecast period. The large market size of oxygenator is primarily attributed to its high cost and acute exchange rate for a different system. The exchange rate of oxygenator is mainly due to mechanical failure, pump head thrombosis, and acute oxygenator thrombosis.

The pumps segment held a considerable market share in 2020 owing to its high cost and usage. The pumps in ECMO machines help pump blood from a patient to artificial lungs that send the blood back to the patient after oxygenation. The growth of the segment is primarily attributed to the high usage of pumps in ECMO procedures and the availability of various types of pumps, such as roller, impeller, and centrifugal. These pumps are used in various applications of ECMO procedures according to their need.

Modality Insights

The veno-arterial segment accounted for the largest share of 41.8% in 2020 and is expected to grow at a healthy CAGR during the forecast period. The largest size of the segment is primarily attributed to its high usage in treating patients with cardiac arrest, assisting with algorithm life support strategies to restore blood circulation.

The veno-venous segment captured a significant share in 2020 and is expected to grow at a lucrative rate during the forecast period. The primary function of the veno-venous ECMO (VV ECMO) circuit is to ease the process of exchange of oxygen and carbon dioxide. Thus, it is a major application in cases where lung support is needed. The increasing incidence of chronic obstructive pulmonary disease is a key factor driving the segment. According to the WHO, there were 251 million cases of COPD globally in 2016 and this number is expected to grow further over the forecast period.

Application Insights

The respiratory segment accounted for the largest share of 43.9% in 2020. The key drivers of the segment include the increasing prevalence of respiratory disorders and rising awareness of ECMO procedures. According to the statistics published by the ELSO, over 2,600 patients suffering from respiratory illnesses in the U.S. underwent ECMO therapy in 2015.

The cardiac surgery segment accounted for a considerable market share in 2020 owing to the increasing incidence of cardiac surgery and rising awareness about ECMO machines in cardiac surgery. According to the American Heart Association, approximately 1 of every 3 deaths in the U.S. were caused by cardiovascular disease in 2016. Moreover, the increasing cost of ECMO procedures, especially in cardiac surgery, is expected to drive the segment. According to a study, the total direct medical costs of cardiovascular diseases are expected to reach USD 749 million by 2035.

Patient Type Insights

The adult segment accounted for the largest share of 59.0% in 2020 and is expected to grow at the fastest rate during the forecast period. Consumption of alcohol, tobacco, and smoking, coupled with a sedentary lifestyle, is increasing the global burden of cardiac and respiratory diseases in adults. According to the report published by the Extracorporeal Life Support Organization, in January 2016, there were around 7,850 adults suffering from cardiac illnesses that required ECMO.

Europe ECPR machine market share, by patient type, 2020 (%)

The pediatric segment accounted for a considerable market share and is expected to grow at a robust pace during the forecast period. The increasing number of children with various pulmonary heart diseases is one of the key drivers of the segment. According to the Extracorporeal Life Support Organization, in January 2016, around 8,102 children suffered from cardiac illness and required ECMO therapy.

Regional Insights

North America dominated the market with a share of 39.8% in 2020 owing to the presence of major players and the increasing number of product launches. The growth of this market in the region can be attributed to the government support for quality healthcare, high purchasing power parity, and the increasing prevalence of diseases, such as chronic obstructive pulmonary disease, in the U.S. and Canada. The presence of sophisticated healthcare facilities and favorable reimbursement policies has led to increased hospital admission rates, which, in turn, is expected to boost the usage rates in this region.

Asia Pacific is expected to witness the fastest growth during the forecast period. Key factors fueling the growth of this regional market include an increase in the healthcare expenditure by the government and private agencies in order to improve healthcare facilities. Economic development in countries, such as Japan, India, and China, coupled with rising government initiatives related to the development of healthcare infrastructure and reimbursement policies, is further expected to augment the market growth.

Key Companies & Market Share Insights

Major players are focused on technological collaboration and product launches. For instance, in February 2016, Terumo Cardiovascular Systems Corporation launched the CAPIOX FX advance oxygenator. This device comprises advanced features, such as increased blood flow rate with a 3,000 ml reservoir and enhanced flow dynamics. Thus, such launches deliver better performance and support market growth. Some of the prominent players in the extracorporeal membrane oxygenation machine market include:

  • Medtronic plc

  • Sorin Group

  • Terumo Cardiovascular Systems Corporation

  • MAQUET Holding B.V. & Co. KG

  • Medos Medizintechnik AG

  • Nipro Medical Corporation

  • Microport Scientific Corporation

Extracorporeal Membrane Oxygenation Machine Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 281.8 million

Revenue forecast in 2028

USD 398.6 million

Growth Rate

CAGR of 5.1% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Component, modality, patient type, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Czech Republic; Russia; Poland; Turkey; Switzerland; China; Japan; India; Australia; South Korea; Vietnam; Philippines; Malaysia; Indonesia; Thailand; Mexico; Brazil; Colombia; Argentina; Chile; South Africa; Saudi Arabia; Oman; Kuwait; UAE

Key companies profiled

Medtronic plc; Sorin Group; Terumo Cardiovascular Systems Corporation; MAQUET Holding B.V. & Co. KG; Medos Medizintechnik AG; Nipro Medical Corporation; Microport Scientific Corporation

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels as well as provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global extracorporeal membrane oxygenation (ECMO) machine market report on the basis of component, modality, patient type, application, and region:

  • Component Outlook (Revenue, USD Million, 2016 - 2028)

    • Pumps

    • Oxygenator

    • Controllers

    • Cannula

    • Accessories

  • Modality Outlook (Revenue, USD Million, 2016 - 2028)

    • Veno-Arterial

    • Veno-Venous

    • Arterio-Venous

  • Patient Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Neonates

    • Pediatric

    • Adult

  • Application Outlook (Revenue, USD Million, 2016 - 2028)

    • Respiratory

      • Neonates

      • Pediatric

      • Adult

    • Cardiac

      • Neonates

      • Pediatric

      • Adult

    • ECPR

      • Neonates

      • Pediatric

      • Adult

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Czech Republic

      • Russia

      • Poland

      • Turkey

      • Switzerland

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Vietnam

      • Philippines

      • Malaysia

      • Indonesia

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

      • Chile

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Oman

      • Kuwait

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.